Regular use of acid reflux drugs, known as proton pump inhibitors, or PPIs for short, is linked to a heightened risk of developing type 2 diabetes, finds research published online in the journal Gut.
Sep 28, 2020
0
440
(HealthDay)—For patients with advanced urothelial cancer treated with atezolizumab, proton pump inhibitor (PPI) use is a negative prognostic marker, according to a study published online Sept. 15 in Clinical Cancer Research.
Sep 16, 2020
0
5
(HealthDay)—Adults taking proton pump inhibitors (PPIs) have an increased risk for having a positive COVID-19 test, with evidence of a dose-response relationship, according to a study published online July 7 in preprint ...
Jul 13, 2020
0
2
Research undertaken by RCSI University of Medicine and Health Sciences suggests that integrating pharmacists into general practice (GP) teams facilitates collaboration to optimise treatment plans for patients with long-term ...
Jun 29, 2020
0
3
Millions of people around the world use proton pump inhibitors for conditions like heartburn, gastritis and stomach ulcers. Researchers at Karolinska Institutet in Sweden now report that the long-term use of these drugs could ...
May 8, 2020
0
464
(HealthDay)—Stomach acid suppression medications increase the odds of intestinal colonization with multidrug-resistant microorganisms (MDROs), according to a review and meta-analysis recently published in JAMA Internal ...
Apr 9, 2020
0
5
Proton pump inhibitors—a widely used class of drugs used to treat acid reflux and related symptoms—may lead to an increased risk of fractures in children and adolescents, reports a study in the Journal of Pediatric Gastroenterology ...
Mar 17, 2020
0
2
Research from Kent's School of Biosciences and the Goethe-University Frankfurt am Main, has found a drug combination that may improve treatment for diseases caused by herpes simplex viruses such as cold sore, genital herpes, ...
Mar 13, 2020
0
28
(HealthDay)—Use of acid reflux drugs (proton pump inhibitors [PPIs]) during and after cancer treatment may be tied to impaired memory and concentration in breast cancer survivors, according to a study recently published ...
Mar 3, 2020
0
1
An investigational drug that binds bile acids in the stomach can reduce the severity of heartburn symptoms in patients with treatment-resistant gastroesophageal reflux disease (GERD) when combined with a proton pump inhibitor ...
Feb 26, 2020
0
1
